AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05751980 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Med Wise Rx
Description: The program consists of two 120-minute classes led by trained community site-based facilitators, designed to help older adults communicate more effectively with their pharmacists.
Study NCT05751980 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Med Wise Rx
Description: The program consists of two 120-minute classes led by trained community site-based facilitators, designed to help older adults communicate more effectively with their pharmacists.
Study NCT06459414 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: : Oropharyngeal Administration Of Colostrum
Description: Preterm less than 34 weeks gestation will receive Oropharyngeal Colostrum for 3 days ( the first group) and for 10 days( the second group)
Study NCT06576557 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KNEE-DEeP intervention- Knowledge translation and exercise for early degenerative knee pain
Description: The intervention for health care professionals (GPs and physiotherapists) will consist of training and education. The two-hour educational workshop for GPs will focus on diagnosis and management of patients with early degenerative knee pain, and enhancing communication skills. Training for physiotherapists will focus on delivery of a 'best practice' session. The patient participant intervention will consist of an 'enhanced consultation' delivered by the GP. This will involve a physical exam, key educational messages, written information and a treatment plan. Patients will receive a single session of physiotherapy within 2 weeks of referral from their GP. This 'best practice' session will focus on self-management skills, targeted patient education, goal setting, action planning and exercise prescription.
Study NCT06640257 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1314 injection
Description: SHR-1314 injection
Study NCT06640257 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SHR-1314 injection
Description: SHR-1314 injection
Study NCT06640257 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05387824 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Bladder Training
Description: Control group All women were informed about BT for 30 minutes. Then it was given as a written brochure to be implemented as a home program.~BT, consisting of four stages, did not contain any PFMT programs in two groups.
Study NCT05387824 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bladder Training
Description: Control group All women were informed about BT for 30 minutes. Then it was given as a written brochure to be implemented as a home program.~BT, consisting of four stages, did not contain any PFMT programs in two groups.
Study NCT05676580 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: cross-linking surgery or intra corneal ring
Description: After keratoconus diagnosis the patient was assigned to surgery
Study NCT05676580 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: abstention
Description: No surgery
Study NCT04591028 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Indocyanine green
Description: A one time injection of IDC prior to the day of scheduled surgery.
Study NCT05195905 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PMEG
Description: All devices that will be modified in this study protocol are commercially available in the United States. The commercially available endografts will be used to construct a fenestrated/branched device for this intervention.
Study NCT05263271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gentulizumab
Description: Gentulizumab will be administered by intravenous infusion once a week, with every 28 days as a dosing cycle .
Study NCT05569668 — intervention group
Intervention type: DRUG
Intervention: Paclitaxel- and platinum-based chemotherapy
Description: Neoadjuvant Chemotherapy
Study NCT06017297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Durvalumab 1500 mg via intravenous (IV) infusion every 3 weeks for up to 8 cycles
Study NCT06017297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tremelimumab
Description: A single dose of tremelimumab at 300mg IV is given on C1.
Study NCT06017297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine is dosed at 1000 mg/m2 IV on day (D)1 and D8 of each cycle.
Study NCT06017297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin is dosed at 25mg/m2 on D1 and D8 of each cycle.
Study NCT06017297 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Resection
Description: If the tumor is evaluated to be resectable (as defined as successfully treated stage II (tumor shrink away from vessels), stage IIIA (tumor shrink away from visceral peritoneum), stage IIIB (N1 disease no longer pathologically enlarged) after C4 or C8, then the patient may proceed with surgical tumor resection.
Study NCT05864079 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Platelet count
Description: Platelet count in study groups
Study NCT05849779 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inhaled sedation with sevoflurane
Description: In both arms, the management of sedation will be conducted in the broader picture of ICU patient care, as per current standard practice in participating ICUs, and following the current guidelines for Pain, Agitation, Delirium, Immobility, and Sleep Disruption (PADIS) published in 2018 by the Society of Critical Care Medicine.~Among many recommendations, this will include the monitoring and titration of both sedation and analgesia using validated scores such as the Richmond Agitation-Sedation Scale (RASS) for sedation. As a result of the current recommendations, the level, dose, and duration of sedation will vary among patients and will be decided by the treating clinicians. The choice of the analgesic drug(s) will be as per the treating clinicians.~Other aspects of critical care will adhere to standard care, including the use of the Checklist for Lung Injury Prevention (CLIP).
Study NCT05849779 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous sedation (current practice)
Description: In both arms, the management of sedation will be conducted in the broader picture of ICU patient care, as per current standard practice in participating ICUs, and following the current guidelines for Pain, Agitation, Delirium, Immobility, and Sleep Disruption (PADIS) published in 2018 by the Society of Critical Care Medicine.~Among many recommendations, this will include the monitoring and titration of both sedation and analgesia using validated scores such as the Richmond Agitation-Sedation Scale (RASS) for sedation. As a result of the current recommendations, the level, dose, and duration of sedation will vary among patients and will be decided by the treating clinicians. The choice of the analgesic drug(s) will be as per the treating clinicians.~Other aspects of critical care will adhere to standard care, including the use of the Checklist for Lung Injury Prevention (CLIP).
Study NCT05226182 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: visualisation of a digital care path
Description: The implementation and visualisation of a digital care path, specifically designed for patients with type 2 diabetes and their care team. The digital care path wil include: 1) a timeline with appointments, messages and questionnaires 2) Diabetes related articles 3) a page for monitoring clinical parameters and goals 4) a section displaying information on their care team and personal health records. The aim of this intervention is to evaluate whether providing a central platform for all data will increase patient empowerment and involvement. Secondly it will also evaluate whether the communication between healthcare professionals improves when selected data is readily available for the entire care team.
Study NCT05180266 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic Touch
Description: Each of the women will be informed about the purpose and content of the study at the first meeting, and informed consent will be obtained from the women who meet the conditions for participation and agree to participate. The pre-test data in the research will be obtained with the Participant Identification Form, PSQI,MRS and MENQOL. After pre-test data collection, women will be given an appointment for therapeutic administration.The therapeutic touch group will be applied to the therapeutic touch group once a week for four weeks in a suitable room in the Faculty of Nursing and on the specified day and time by the researcher.At the end of the fourth week, post-test data will be obtained by filling in PSQI, MRS and MENQOL again.
Study NCT05180266 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Listening Group
Description: Each of the women was informed about the purpose and content of the study at the first meeting, and informed consent was obtained from the women who met the conditions for participation and accepted to participate.The pre-test data in the research will be obtained with the Participant Identification Form, PSQI, MRS and MENQOL. Music stream, music will be uploaded to mobile phones. He will be asked to listen to music (relaxation music in the relaxation exercises CD prepared by the Turkish Psychological Association) for 30 minutes before going to sleep every day for four weeks. At the end of the fourth week, post-test data will be obtained by filling in PSQI, MRS and MENQOL again
Study NCT05180266 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: Each of the women will be informed about the purpose and content of the study at the first meeting, and informed consent will be obtained from the women who meet the conditions for participation and agree to participate.The pre-test data in the research will be obtained with the Participant Identification Form, PSQI, MRS and MENQOL. No action will be taken on the control group for four weeks. At the end of the fourth week, post-test data will be obtained by filling in PSQI, MRS and MENQOL again.
Study NCT06311760 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0292
Description: AZD0292 will be administered as single dose via IV infusion.
Study NCT06311760 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered as IV infusion.
Study NCT05311800 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity
Description: Comparison of HIIT mode (running vs cycling)
Study NCT05120089 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: muscle energy technique and myofacial release (physiotherapy techniques)
Description: Each technique will be applied for three month (3 session/week)
Study NCT04791280 — intervention group
Intervention type: PROCEDURE
Intervention: Faeces collection
Description: * faeces collection at inclusion~* follow-up visit 6 months after inclusion
Study NCT04866615 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Optvue OCT
Description: Optical coherence tomography
Study NCT05602649 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Cannabis will be orally ingested
Study NCT05602649 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be orally ingested
Study NCT06108375 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: music therapy
Description: music played live by a music therapist
Study NCT06108375 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: recording
Description: a recording of the same music played by the music therapist
Study NCT06579976 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: This is an observational study, no intervention will be implemented.
Study NCT05019664 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Affixus Natural Nail System
Description: Intramedullary nailing designed for fixation and stabilization of fractures or osteotomies of the humerus. Nails are comprised of proximal and antegrade/retrograde.
Study NCT06578884 — intervention group
Intervention type: DEVICE
Intervention: 877PTY
Description: IOL implantation with 6-month follow-up period Monocular UDVA/CDVA Manifest Refraction (SPH, CYL, SEQ) Optical Biometry, Keratometry (K1, K2, AXL, ACD) IOL axis orientation determination Visual function questionnaire Glistening evaluation Tonometry Slit-Lamp examination Fundus visualization
Study NCT05995028 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Universal CD7-specific CAR gene-engineered T cells
Description: Infusion of 4SCAR7U T cells
Study NCT05864079 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Developmental endothelial locus-1 (DEL-1)
Description: Serum DEL-1 in study groups
Study NCT05864079 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: soluble P-selectin (sP-sel)
Description: Serum sP-sel in study groups
Study NCT05356195 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CTX001
Description: Administered by intravenous infusion following myeloablative conditioning with busulfan.
Study NCT05433532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine: 75mg/m2 qd, d1-d7, subcutaneous injection
Study NCT05433532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Venetoclax: 100mg d1, 200mg d2, 300mg d3, 400mg d4-d14 or 21, oral (Adjusted according to the peripheral blood BCR/ABL1 results on day 14)
Study NCT05433532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flumatinib
Description: Flumatinib: 600mg qd, d4-d21, oral
Study NCT05878002 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: polysomnography
Description: Sleep study through polysomnographic examination
Study NCT06476912 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: weight-shifting exercise
Description: lateral weight-shifting balance training and VNS
Study NCT04235335 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Indigenous Mother's Empowerment Program & Indigenous Kid's Club Program
Description: Weekly groups administered to mothers and children simultaneously but separately for 10 weeks
Study NCT05018884 — intervention group
Intervention type: PROCEDURE
Intervention: Observation of surgical site infections
Description: No intervention is done, only observation of routine clinical practice
Study NCT06476912 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: weight-shifting exercise
Description: lateral weight-shifting balance training and VNS
Study NCT05374902 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Providing procedural informational animation video
Description: Children and parents have watched procedural informational animation before venipuncture. Afterward, the children and their parents entered the blood drawn unit, and the procedure was performed as in standard care.
Study NCT05374902 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Buzzy
Description: Buzzy® was placed on the injection site and it was turned on 60 s before the procedure. Then, the nurse moved Buzzy® about 3-5 cm above the injection site. The procedure was performed with buzzy®. The Buzzy® intervention and phlebotomy were terminated at the same time.
Study NCT05374902 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Multiple interventions
Description: Watching procedural informational animation video prior to venipuncture, and Buzzy application during venipuncture
Study NCT05903625 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Control Group - Standard White Bread
Description: Participants consume commercially available standard white bread, serving as the control intervention.
Study NCT05903625 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lysine Group - Lysine-Fortified Bread
Description: Participants consume bread fortified with lysine, an essential amino acid, in a specified dosage, frequency, and duration.
Study NCT05903625 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Phosphorus Group - Phosphorus-Fortified Bread
Description: Participants consume bread fortified with phosphorus, an essential mineral, in a specified dosage, frequency, and duration
Study NCT05903625 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lysine and Phosphorus Group - Double Fortified Bread
Description: Double Fortified Bread: Participants consume bread fortified with both lysine and phosphorus in specified dosages, frequencies, and durations.
Study NCT06315829 — intervention group
Intervention type: DEVICE
Intervention: Spasm Vision
Description: Machine learning software developed to analyze videos and accurately distinguish infantile spasms from visually similar movements.
Study NCT06666842 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Noom Weight
Description: Participants assigned to Noom Weight will be provided access to the app-based program for 16 weeks. This program offers access to self-monitoring features, psychoeducational articles, one-on-one coaching from health experts, and group support. The app includes a robust database of foods, allowing users to track their energy intake. Self-monitoring via the app enables users to review and monitor behavior and weight change patterns. Daily articles review principles of behavior change, nutrition, exercise, etc.
Study NCT06666842 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Educational Control
Description: Participants assigned to the educational control will receive 16 brief (5-10 minute read) weekly newsletters outlining information on developing and maintaining a healthy diet and lifestyle adapted from the 2015-2020 Department of Health and Human Services (HHS) and Department of Agriculture (USDA) Dietary Guidelines for Americans. Newsletters include detailed information on topics such as nutrition fundamentals (e.g., calorie limits; healthy eating), food groups and dietary guidelines (e.g., importance of vegetables, fruits, and grains), and tips for habit change (e.g., reducing added sugar and saturated fats). Each week includes prompts for individuals to try new strategies (e.g., make a conscious decision about everything you eat; try to eat at your calorie budget).
Study NCT06661954 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bed A - supine
Description: Hercules dream air surface in supine position
Study NCT06661954 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bed B - supine
Description: Oncare Skinguard surface
Study NCT06661954 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bed A - head of bed at 30 degrees
Description: Hercules dream air surface with head of bed at 30 degrees
Study NCT06661954 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bed B - head of bed at 30 degrees
Description: Oncare Skinguard surface with head of bed at 30 degrees
Study NCT06608563 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fissure sealant without adhesive system (NO BOND)
Description: 1. Cotton roll isolation~2. Etching of the enamel surface: 17% phosphoric 15 seconds over the surface to be sealed (Phosphoric etchant gel - Vococid, VOCO)~3. Washing/drying: a 3-1 syringe will be used to rinse all etch material from the toothsurface.~4. Sealant application: a light-curing nano-hybrid fissure sealant material (Grandio Seal; VOCO) will be applied using the applicator tip.~5. Lightcuring: The material will be lightcured for 20 seconds.
Study NCT06608563 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fissure sealant with adhesive system (BOND)
Description: 1. Cotton roll isolation~2. Etching of the enamel surface: 17% phosphoric 15 seconds over the surface to be sealed (Phosphoric etchant gel - Vococid, VOCO)~3. Washing/drying: a 3-1 syringe will be used to rinse all etch material from the toothsurface.~4. Adhesive system application: the adhesive system (Futurabond, VOCO) single dose capsule will be applied over the surface to be sealed for 5 seconds using a microbrush. The adhesive system will be air thin dried and lightcured for 10s before sealant placement.~5. Sealant application: a light-curing nano-hybrid fissure sealant material (Grandio Seal; VOCO) will be applied using the applicator tip.~6. Lightcuring: The material will be lightcured for 20 seconds.
Study NCT06667778 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Osseodesification densah burs
Description: Drill no. VT1525 (2mm) of densah burs will be used first in counter clockwise (in the osteotomy site).~Then drill no. VT2535 (3mm) of densah burs will be used in counter clockwise to put 3.5mm implant diameter.
Study NCT06667778 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Microdent
Description: No. 1 Microdent expander will be placed and screwed slowely (to avoid heat generation) into the osteotomy site till reaching the full desired length.~N0. 2 microdent expander will be placed and screwed into the osteotomy site as the same step.~Then no. 3 Microdent expander will be inserted for placing 3.5mm implant diameter
Study NCT06683131 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tafolecimab
Description: 450mg of tafolecimab (150mg each one) was injected subcutaneously before primary PCI and then every month till totally 12 months.
Study NCT06681948 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Description: Ketogenic diet
Study NCT06681948 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT06685003 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Digital Tutorial overview
Description: Self study of a digital tutorial covering an overview of CRAFT designed to be reviewed within 7 weeks and revisited over 6 months.
Study NCT06685003 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Tutorial overview
Description: Self study of a digital tutorial covering an overview of CRAFT designed to be reviewed within 7 weeks and revisited over 6 months.